Literature DB >> 19932972

Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides: part II.

William J Moore1, Jeffrey C Kern, Ramesh Bhat, Peter V N Bodine, Shoichi Fukyama, Girija Krishnamurthy, Ronald L Magolda, Keith Pitts, Barb Stauffer, Eugene J Trybulski.   

Abstract

Piperidinyl diphenylsulfonyl sulfonamides are a novel class of molecules that have inhibitory binding affinity for sFRP-1. As a secreted protein sFRP-1 inhibits the function of the secreted Wnt glycoprotein. Therefore, as inhibitors of sFRP-1 these small molecules facilitate the Wnt/beta-catenin canonical signaling pathway. Details of the structure-activity relationships and biological activity of this structural class of compounds will be discussed. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932972     DOI: 10.1016/j.bmc.2009.11.002

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

Review 1.  Update on Wnt signaling in bone cell biology and bone disease.

Authors:  David G Monroe; Meghan E McGee-Lawrence; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Gene       Date:  2011-11-03       Impact factor: 3.688

Review 2.  Development of small molecules targeting the Wnt pathway for the treatment of colon cancer: a high-throughput screening approach.

Authors:  Wei Chen; Minyong Chen; Larry S Barak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-05-27       Impact factor: 4.052

3.  Wnt signaling in bone formation and its therapeutic potential for bone diseases.

Authors:  Jeong Hwan Kim; Xing Liu; Jinhua Wang; Xiang Chen; Hongyu Zhang; Stephanie H Kim; Jing Cui; Ruidong Li; Wenwen Zhang; Yuhan Kong; Jiye Zhang; Wei Shui; Joseph Lamplot; Mary Rose Rogers; Chen Zhao; Ning Wang; Prashant Rajan; Justin Tomal; Joseph Statz; Ningning Wu; Hue H Luu; Rex C Haydon; Tong-Chuan He
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-02       Impact factor: 5.346

Review 4.  The role of small molecules in musculoskeletal regeneration.

Authors:  Kevin W-H Lo; Keshia M Ashe; Ho Man Kan; Cato T Laurencin
Journal:  Regen Med       Date:  2012-07       Impact factor: 3.806

Review 5.  Sclerosing bone dysplasias: leads toward novel osteoporosis treatments.

Authors:  Igor Fijalkowski; Eveline Boudin; Geert Mortier; Wim Van Hul
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

Review 6.  WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Authors:  Roland Baron; Michaela Kneissel
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

Review 7.  WNT Signaling in Cardiac and Vascular Disease.

Authors:  Sébastien Foulquier; Evangelos P Daskalopoulos; Gentian Lluri; Kevin C M Hermans; Arjun Deb; W Matthijs Blankesteijn
Journal:  Pharmacol Rev       Date:  2018-01       Impact factor: 25.468

8.  Apoptosis associated with Wnt/β-catenin pathway leads to steroid-induced avascular necrosis of femoral head.

Authors:  Chen Zhang; Yu-Long Zou; Jun Ma; Xiao-Qian Dang; Kun-Zheng Wang
Journal:  BMC Musculoskelet Disord       Date:  2015-06-03       Impact factor: 2.362

9.  Arsenic trioxide inhibits viability and induces apoptosis through reactivating the Wnt inhibitor secreted frizzled related protein-1 in prostate cancer cells.

Authors:  Lei Zheng; Hui Jiang; Zhi-Wei Zhang; Ke-Nan Wang; Qi-Fei Wang; Quan-Lin Li; Tao Jiang
Journal:  Onco Targets Ther       Date:  2016-02-23       Impact factor: 4.147

10.  Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling.

Authors:  Elliott D Bayle; Fredrik Svensson; Benjamin N Atkinson; David Steadman; Nicky J Willis; Hannah L Woodward; Paul Whiting; Jean-Paul Vincent; Paul V Fish
Journal:  J Med Chem       Date:  2021-03-30       Impact factor: 7.446

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.